rhodamine b has been researched along with paclitaxel in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thakker, DR; Troutman, MD | 1 |
| Shi, L; Tang, C; Yin, C | 1 |
| Chang, J; Hao, XD; Liu, HR; Sun, X; Xie, C; Yu, JM | 1 |
| Catalano, P; Colby, A; Colson, YL; Grinstaff, MW; Hofferberth, SC; Lei, H; Liu, R; Tevis, KM | 1 |
4 other study(ies) available for rhodamine b and paclitaxel
| Article | Year |
|---|---|
Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blotting, Western; Cells, Cultured; Diffusion; Humans; Intestinal Absorption; Intestinal Mucosa; Models, Biological; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2003 |
Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Death; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Endocytosis; Female; Glycyrrhizic Acid; Humans; Liver; Liver Neoplasms; Mice; Nanoparticles; Paclitaxel; Particle Size; Rhodamines; Spectroscopy, Fourier Transform Infrared; Static Electricity; Subcellular Fractions; Tissue Distribution; Treatment Outcome; Tumor Burden | 2012 |
Mitochondrial-targeted prodrug cancer therapy using a rhodamine B labeled fluorinated docetaxel.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Docetaxel; Drug Delivery Systems; Fluorine; Hep G2 Cells; Humans; Liver Neoplasms; Microscopy, Fluorescence; Mitochondria; Optical Imaging; Paclitaxel; Prodrugs; Rhodamines; Taxoids; Time Factors | 2013 |
Paclitaxel-loaded expansile nanoparticles enhance chemotherapeutic drug delivery in mesothelioma 3-dimensional multicellular spheroids.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carboxylic Acids; Cell Line, Tumor; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Ethanol; Excipients; Fluorescent Dyes; Glycerol; Humans; Kinetics; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Microscopy, Confocal; Nanomedicine; Nanoparticles; Paclitaxel; Pinocytosis; Rhodamines; Spheroids, Cellular; Technology, Pharmaceutical | 2015 |